Skip to main content
Premium Trial:

Request an Annual Quote

Merck KGaA to Distribute RevoluGen's High Molecular Weight DNA Extraction Product

NEW YORK – UK reagent firm RevoluGen said today that it has signed a global distribution agreement with Merck KGaA for its DNA extraction and size selection product.

Under the non-exclusive agreement, Merck KGaA, based in Darmstadt, Germany, will distribute RevoluGen's Fire Monkey/Fire Flower kit, which uses spin columns to extract high molecular weight DNA with an average length of 100 kb or more from animal and bacterial cells, followed by the removal of DNA fragments smaller than 10 kb.

"With this agreement we are able to provide more customers with access to RevoluGen's Fire Monkey/Fire Flower product for producing the clean and high molecular weight DNA (HMW-DNA) needed for long-read sequencing," said RevoluGen CEO Pieter Haitsma Mulier in a statement.

Long-read sequencing is one of the main applications of RevoluGen's technology. "Users of Oxford Nanopore's sequencing technology continue to publish novel biology using very long reads, and will be delighted to have greater access to this fast kit for high molecular weight DNA extraction," said Gordon Sanghera, CEO of Oxford Nanopore Technologies, in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.